Jan 05, 2022
Myriad Genetics CEO Paul Diaz to Speak at 40th Annual J.P. Morgan Health Care Conference
Corporate
Jan 04, 2022
Myriad Genetics Chief Scientific Officer Jerry Lanchbury Retires after 19 Years of Service
Corporate
Dec 15, 2021
New Year’s Resolutions: Americans Say Body & Mind Equally Important in Theory but Not in Practice, According to GeneSight® Mental Health Monitor Nationwide Survey
Products
Dec 14, 2021
Myriad Genetics Promotes Nicole Lambert to Chief Operating Officer
Corporate
Nov 23, 2021
The New Generation Gap: Nationwide Survey Finds Different Perspectives on Anxiety Between Parents, Young Adults
Products
Nov 22, 2021
Myriad Genetics to Present New Data at San Antonio Breast Cancer Symposium Highlighting Value of Genetic Testing in Breast Cancer Risk Assessment and Treatment
Pipeline
Nov 02, 2021
Myriad Genetics Reports Third Quarter 2021 Results, Continues Strong Execution of Strategic Growth & Transformation Plans
Financial
Oct 27, 2021
Myriad Genetics to Release Third Quarter Financial Results on November 2, 2021
Financial
Oct 18, 2021
Myriad Genetics Names Pamela Wong as Chief Legal Officer
Corporate
Oct 11, 2021
Americans’ anxiety impacted by the ongoing pandemic, yet 1 in 5 say they won’t seek treatment according to the GeneSight® Mental Health Monitor nationwide survey
Products
Sep 13, 2021
Myriad Genetics Completes Sale of Myriad Autoimmune’s Vectra Testing Business to LabCorp
Corporate
Sep 08, 2021
Only 8% of people remain hopeful after depression medication fails them, according to GeneSight® Mental Health Monitor nationwide survey
Products
Aug 03, 2021
Myriad Genetics Delivers Strong Revenue and Earnings Growth in June 2021 Quarter, Continues to Execute on Strategic Growth & Transformation Plans
Financial
Aug 02, 2021
Myriad Genetics Expands Access to Genetic Testing with Launch of First Polygenic Breast Cancer Risk Assessment Score Validated for Women of All Ancestries
Pipeline
Jul 28, 2021
Myriad Genetics to Release Second Quarter Financial Results on August 3, 2021
Financial